Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Association of sulfonylureas with the risk of dementia: A population‐based cohort study
Che‐Yuan Wu, Carina Iskander, Christa Wang, et al.
Journal of the American Geriatrics Society (2023) Vol. 71, Iss. 10, pp. 3059-3070
Open Access | Times Cited: 19

Showing 19 citing articles:

Sodium-glucose cotransporter-2 inhibitors and their potential role in dementia onset and cognitive function in patients with diabetes mellitus: a systematic review and meta-analysis
Y J Youn, Seung Yeon Kim, Hyun‐Jeong Jeong, et al.
Frontiers in Neuroendocrinology (2024) Vol. 73, pp. 101131-101131
Open Access | Times Cited: 23
Association between use of sodium-glucose co-transporter-2 inhibitor and the risk of incident dementia: a population-based cohort study
Zarin Abdullah, Ying Cui, Robert W. Platt, et al.
BMJ Open Diabetes Research & Care (2025) Vol. 13, Iss. 1, pp. e004541-e004541
Open Access | Times Cited: 2
Mitochondria and the Repurposing of Diabetes Drugs for Off-Label Health Benefits
Joyce Yip, Grace Shu Hui Chiang, I Lee, et al.
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 1, pp. 364-364
Open Access | Times Cited: 1
Diabetes-Alzheimer's connection in older age: SGLT2 inhibitors as promising modulators of disease pathways
Francesca Mancinetti, Dionysios P. Xenos, Michelantonio De Fano, et al.
Ageing Research Reviews (2023) Vol. 90, pp. 102018-102018
Closed Access | Times Cited: 20
Repurposing antidiabetic drugs for Alzheimer's disease: A review of preclinical and clinical evidence and overcoming challenges
Jacky Tran, Sneh Parekh, Julia Rockcole, et al.
Life Sciences (2024) Vol. 355, pp. 123001-123001
Closed Access | Times Cited: 8
Association of sodium‐glucose cotransporter 2 inhibitors with risk of incident dementia and all‐cause mortality in older patients with type 2 diabetes: A retrospective cohort study using the TriNetX US collaborative networks
Yen‐Wei Pai, I‐Chieh Chen, Jun‐Fu Lin, et al.
Diabetes Obesity and Metabolism (2024)
Closed Access | Times Cited: 8
Risk of Dementia and Alzheimer's Disease Associated With Antidiabetics: A Bayesian Network Meta-Analysis
Yongjun Sunwoo, Jaeho Park, Chang-Young Choi, et al.
American Journal of Preventive Medicine (2024) Vol. 67, Iss. 3, pp. 434-443
Closed Access | Times Cited: 6
Association Between Type 2 Diabetes Mellitus and Alzheimer's Disease: Common Molecular Mechanism and Therapeutic Targets
Aparna Chauhan, Sachin Dubey, Smita Jain
Cell Biochemistry and Function (2024) Vol. 42, Iss. 7
Closed Access | Times Cited: 5
Dopamine in the Regulation of Glucose Homeostasis, Pathogenesis of Type 2 Diabetes, and Chronic Conditions of Impaired Dopamine Activity/Metabolism: Implication for Pathophysiological and Therapeutic Purposes
Giuseppe Lisco, Anna De Tullio, Michele Iovino, et al.
Biomedicines (2023) Vol. 11, Iss. 11, pp. 2993-2993
Open Access | Times Cited: 11
Effect of diabetes medications on the risk of developing dementia, mild cognitive impairment, or cognitive decline: A systematic review and meta-analysis
Esther K. Hui, Naaheed Mukadam, Gianna Kohl, et al.
Journal of Alzheimer s Disease (2025)
Closed Access
Anti-diabetic agents and the risks of dementia in patients with type 2 diabetes: a systematic review and network meta-analysis of observational studies and randomized controlled trials
Zonglin Li, Chu Lin, Xiaoling Cai, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 3
No association between metformin initiation and incident dementia in older adults newly diagnosed with diabetes
Che‐Yuan Wu, Christa Wang, Refik Saskin, et al.
Journal of Internal Medicine (2023) Vol. 295, Iss. 1, pp. 68-78
Open Access | Times Cited: 7
Anti-diabetics and the Prevention of Dementia: A Systematic Review
Ethan Slouha, Fadi Ibrahim, Atbeen Rezazadah, et al.
Cureus (2023)
Open Access | Times Cited: 5
Increased risk of dementia in older adults starting sulfonylurea: taking sulfonylurea off the list
Danielle Pessoa Lima, Lucas Tadeu Rocha Santos
Evidence-Based Nursing (2024), pp. ebnurs-103791
Closed Access | Times Cited: 1
Phosphodiesterase-5 Inhibitors and Dementia Risk: A Real-World Study
Naomi Gronich, Nili Stein, Walid I. Saliba
Neuroepidemiology (2024), pp. 1-10
Open Access | Times Cited: 1
Translational research on cognitive impairment in chronic kidney disease
Carsten A. Wagner, Ziad A. Massy, Giovambattista Capasso, et al.
Nephrology Dialysis Transplantation (2024)
Closed Access | Times Cited: 1
Disease latency and new‐user versus prevalent‐user cohort designs: Implications for pharmacoepidemiology in dementia
Che‐Yuan Wu, Walter Swardfager
Journal of the American Geriatrics Society (2023) Vol. 72, Iss. 3, pp. 953-955
Open Access | Times Cited: 2
Reply to: Comment on: Association of sulfonylureas with the risk of dementia: A population‐based cohort study
Che‐Yuan Wu, Walter Swardfager
Journal of the American Geriatrics Society (2024) Vol. 72, Iss. 4, pp. 1290-1291
Open Access
Modern views on pathogenesis of cognitive impairment in patients with type 2 diabetes mellitus
T. Yu. Demidova, A. S. Teplova, V. O. Yarmanova
Meditsinskiy sovet = Medical Council (2024), Iss. 16, pp. 265-273
Open Access
Page 1

Scroll to top